BRD2 and myeloid sarcoma: Because chronically activated TEMs (CD45RO+CCR7-) are the major infiltrating cell type in MS brains (Rus et al, 2005), their selective removal would be a valuable strategy, as it could lead to their definitive elimination from the circulation of patients undergoing NAT treatment.